blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3022303

EP3022303 - METHODS OF TREATING UROTHELIAL CARCINOMAS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.09.2024
Database last updated on 18.11.2024
FormerThe patent has been granted
Status updated on  29.09.2023
FormerGrant of patent is intended
Status updated on  21.05.2023
FormerExamination is in progress
Status updated on  21.03.2023
FormerGrant of patent is intended
Status updated on  22.11.2022
FormerExamination is in progress
Status updated on  06.07.2018
Most recent event   Tooltip01.11.2024Lapse of the patent in a contracting state
New state(s): SI		published on 04.12.2024 [2024/49]
Applicant(s)For all designated states
Foundation Medicine, Inc.
150 Second Street
Cambridge, MA 02141 / US
[2023/44]
Former [2016/21]For all designated states
Foundation Medicine, Inc.
150 Second Street
Cambridge, MA 02141 / US
Inventor(s)01 / ALI, Siraj, Mahamed
Foundation Medicine, Inc.
150 Second Street
Cambridge, MA 02141 / US
02 / HAWRYLUK, Matthew, J.
20 Watertown Street
Unit 206
Watertown, MA 02472 / US
03 / ROSS, Jeffrey, S.
7 Bird Road
Lebanon Springs, NY 12125 / US
04 / STEPHENS, Philip, James
25 Swan Lane
Lexington, MA 02421 / US
 [2016/26]
Former [2016/21]01 / ALI, Siraj, Mahamed
13 Ellery St. Apt 3
Cambridge, MA 02138 / US
02 / HAWRYLUK, Matthew, J.
20 Watertown Street
Unit 206
Watertown, MA 02472 / US
03 / ROSS, Jeffrey, S.
7 Bird Road
Lebanon Springs, NY 12125 / US
04 / STEPHENS, Philip, James
25 Swan Lane
Lexington, MA 02421 / US
Representative(s)CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London EC4N 6AF / GB
[2023/44]
Former [2016/21]Miller, David James, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
Application number, filing date14826369.216.07.2014
[2016/21]
WO2014US46857
Priority number, dateUS201361847532P17.07.2013         Original published format: US 201361847532 P
[2016/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015009831
Date:22.01.2015
Language:EN
[2015/03]
Type: A2 Application without search report 
No.:EP3022303
Date:25.05.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 22.01.2015 takes the place of the publication of the European patent application.
[2016/21]
Type: B1 Patent specification 
No.:EP3022303
Date:01.11.2023
Language:EN
[2023/44]
Search report(s)International search report - published on:US07.05.2015
(Supplementary) European search report - dispatched on:EP21.02.2017
ClassificationIPC:C12N15/113, A61K31/7088, A61K39/395, C12Q1/68, A61P35/00
[2022/48]
CPC:
A61K31/517 (EP,US); A61K31/475 (EP,US); A61K31/519 (EP,US);
A61K31/5365 (EP,US); A61K31/704 (EP,US); A61K31/7105 (EP,US);
A61K31/713 (EP,US); A61K33/243 (EP,US); A61K45/06 (EP,US);
A61K47/6851 (EP,US); A61K47/6855 (US); C07K14/82 (EP,US);
C07K16/32 (EP,US); C12Q1/6886 (EP,US); C12Q2600/106 (EP,US) (-)
C-Set:
A61K31/475, A61K2300/00 (US,EP);
A61K31/519, A61K2300/00 (EP,US);
A61K31/704, A61K2300/00 (US,EP);
A61K31/7105, A61K2300/00 (EP,US);
A61K31/713, A61K2300/00 (EP,US);
A61K33/24, A61K2300/00 (US,EP)
(-)
Former IPC [2016/21]C12N15/113, A61K31/7088, A61K39/395, C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/21]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON UROTHELIALEN KARZINOMEN[2016/21]
English:METHODS OF TREATING UROTHELIAL CARCINOMAS[2016/21]
French:MÉTHODES DE TRAITEMENT DE CARCINOMES UROTHÉLIAUX[2016/21]
Entry into regional phase03.02.2016National basic fee paid 
03.02.2016Search fee paid 
03.02.2016Designation fee(s) paid 
03.02.2016Examination fee paid 
Examination procedure03.02.2016Examination requested  [2016/21]
20.09.2017Amendment by applicant (claims and/or description)
09.07.2018Despatch of a communication from the examining division (Time limit: M06)
18.01.2019Reply to a communication from the examining division
17.01.2020Despatch of a communication from the examining division (Time limit: M04)
21.05.2020Reply to a communication from the examining division
25.01.2021Despatch of a communication from the examining division (Time limit: M06)
03.08.2021Reply to a communication from the examining division
14.03.2022Despatch of a communication from the examining division (Time limit: M04)
22.07.2022Reply to a communication from the examining division
23.11.2022Communication of intention to grant the patent
21.03.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.05.2023Communication of intention to grant the patent
21.09.2023Fee for grant paid
21.09.2023Fee for publishing/printing paid
21.09.2023Receipt of the translation of the claim(s)
Opposition(s)02.08.2024No opposition filed within time limit [2024/41]
Fees paidRenewal fee
27.07.2016Renewal fee patent year 03
27.07.2017Renewal fee patent year 04
27.07.2018Renewal fee patent year 05
29.07.2019Renewal fee patent year 06
14.07.2020Renewal fee patent year 07
15.07.2021Renewal fee patent year 08
15.06.2022Renewal fee patent year 09
14.06.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT01.11.2023
CZ01.11.2023
DK01.11.2023
EE01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RO01.11.2023
RS01.11.2023
SE01.11.2023
SI01.11.2023
SK01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
[2024/49]
Former [2024/36]AT01.11.2023
CZ01.11.2023
DK01.11.2023
EE01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RO01.11.2023
RS01.11.2023
SE01.11.2023
SK01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/35]AT01.11.2023
CZ01.11.2023
DK01.11.2023
EE01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RO01.11.2023
RS01.11.2023
SE01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/34]AT01.11.2023
DK01.11.2023
EE01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/33]AT01.11.2023
DK01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/26]AT01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/25]AT01.11.2023
HR01.11.2023
LT01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/24]AT01.11.2023
HR01.11.2023
LT01.11.2023
NL01.11.2023
RS01.11.2023
SE01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/23]AT01.11.2023
LT01.11.2023
NL01.11.2023
BG01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/21]LT01.11.2023
NL01.11.2023
BG01.02.2024
GR02.02.2024
IS01.03.2024
Former [2024/20]GR02.02.2024
IS01.03.2024
Documents cited:Search[XY]WO2013063229  (UNIV MICHIGAN [US], et al);
International search[Y]US2006034840  (AGUS DAVID B [US]);
 [Y]US2009318480  (SOLCA FLAVIO [AT]);
 [Y]WO2010093465  (CARIS MPI INC [US], et al);
 [Y]WO2011147986  (GENMAB AS [DK], et al);
by applicantUS4366241
 US4376110
 US4517288
 WO8809810
 US4837168
 US4868103
 WO8910134
 US4987071
 EP0430402
 US5093246
 US5116742
 US5223409
 WO9416101
 WO9421822
 US5491224
 US5547835
 US5605798
 US5631169
 US6277569
 US6455258
 US2003143204
 US2003166282
 US2003224432
 US2004038278
 US2004086884
 US2010029498
 WO2012092426
 WO1996US03651
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.